In vitro evaluation of the effect of the opioid antagonist N-methylnaltrexone on motility of the equine jejunum and pelvic flexure.
Authors: van Hoogmoed L M, Boscan P L
Journal: Equine veterinary journal
Summary
# Editorial Summary: N-methylnaltrexone and Equine Intestinal Motility Opioid analgesics present a clinical paradox in equine medicine: whilst providing essential pain relief, they suppress intestinal activity and risk precipitating ileus—a particularly serious complication in horses. Van Hoogmoed and Boscan investigated whether N-methylnaltrexone (MNTX), a peripherally acting opioid antagonist that cannot cross the blood-brain barrier, might restore jejunal and pelvic flexure motility in vitro without compromising analgesia. Using isolated equine intestinal tissue preparations, the researchers demonstrated that MNTX directly stimulated muscle contractions in both the jejunum and pelvic flexure, reversing the motor-suppressing effects of morphine whilst leaving analgesic properties intact. This work is significant because it provides the first evidence that MNTX could potentially allow clinicians to administer adequate opioid analgesia in post-surgical or colic cases without accepting reduced gut function as an inevitable trade-off. Whilst further in vivo studies were needed to confirm these findings in the living horse, the results suggested MNTX warrants investigation as a pharmacological tool to mitigate opioid-induced ileus in equine practice.
Read the full abstract on PubMed
Practical Takeaways
- •MNTX may offer a pharmacological solution to opioid-induced ileus in horses by maintaining pain relief while restoring gut motility—potentially improving post-operative and post-injury outcomes
- •This in vitro work provides preliminary evidence supporting further clinical evaluation of MNTX in equine practice for managing opioid-related constipation and ileus
- •Consider discussing opioid antagonists with your veterinarian when pain management in horses requires analgesics but ileus risk is high
Key Findings
- •N-methylnaltrexone (MNTX) is an opioid antagonist that does not cross the blood-brain barrier, preserving analgesia while antagonising morphine's intestinal effects
- •MNTX directly stimulates motility and restores intestinal function in equine jejunum and pelvic flexure in vitro
- •No prior information existed regarding MNTX usage in horses at the time of publication